/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that five new presentations related to Peyronie's disease, or PD, and XIAFLEX® (collagenase...

Related Keywords

San Diego , California , United States , Canada , Dublin , Ireland , Canadian , Ranjith Ramasamy , Jill Davis , Marian Ayad , Sajel Patel , Joshua Henderson , Klinton Brearton , Matthew Ziegelmann , Gregoryj Kaufman , Gregorya Broderick , Tina Rezakhani , Femida Gwadry Sridhar , Jeffrey Andrews , Marc Mason , Briley Warner , Greg Kaufman , David Hurley , Landon Trost , Mohit Khera , Angel Cronin , Bryce Palmer , Jamesp Tursi , Tobias Kohler , Henry Larson , Psexual Medicine Society Of North America , Prnewswire Endo International , Endo International , Linkedin , Exchange Commission , Sexual Medicine Society , North America , Jesse Mills , Disease Patients , Penile Pain , Baseline Treated , Collagenase Clostridium Histolyticum , Post Hoc Analysis , Validate Effectiveness , Registry Design , Ventral Curvatures , Joshua Savage , Collagenase Clostridium Histolyticum Protocol , Disease Among Prior Non Responders , Single Blinded Study , Sevann Helo , Randomized Trial , Post Hoc Phase , Disease Questionnaire , Risk Evaluation , Mitigation Strategy , Including Anaphylaxis , Abnormal Coagulation , Post Injection Back Pain Reactions , Prescribing Information , Boxed Warning , Private Securities Litigation Reform Act , Bankruptcy Code , Annual Report , Quarterly Reports , Endo International Plc ,